Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sanofi
Sanofi
Incyte, itching for a piece of Dupixent's market, hits goals in midphase skin disease trial
Fierce Biotech
Mon, 03/11/24 - 11:52 am
Incyte
clinical trials
prurigo nodularis
povorcitinib
Dupixent
Sanofi
Regeneron
RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter
Stat
Thu, 03/7/24 - 05:35 pm
Sanofi
AstraZeneca
Beyfortus
RSV
monoclonal antibodies
With Sanofi left as the lone supplier of tetanus shots in the US, CDC warns of shortage
Fierce Pharma
Fri, 03/1/24 - 11:50 am
CDC
Sanofi
tetanus
vaccines
drug shortages
Takeda’s Eohilia to compete Sanofi’s Dupixent in eosinophilic esophagitis treatment
Clinical Trials Arena
Thu, 02/29/24 - 11:11 am
Takeda
Eohilia
Sanofi
Dupixent
EoE
eosinophilic esophagitis
Sanofi CEO Hudson takes another small dip in pay to €10.57M
Fierce Pharma
Mon, 02/26/24 - 05:15 pm
Sanofi
Pharma CEOs
Paul Hudson
executive compensation
Sanofi looks to advance CSU drug rilzabrutinib in Phase III trial
Clinical Trials Arena
Mon, 02/26/24 - 10:35 am
Sanofi
rilzabrutinib
chronic spontaneous urticaria
clinical trials
Sanofi, Regeneron Secure FDA Priority Review for Dupixent in COPD
BioSpace
Fri, 02/23/24 - 10:43 am
FDA
Sanofi
Regeneron
Dupixent
priority review
COPD
Sanofi's planned consumer health spinoff picks up interest from multiple firms
Fierce Pharma
Wed, 02/21/24 - 10:35 pm
Sanofi
consumer healthcare
spinoffs
Fabrazyme litigation back in play for Sanofi's Genzyme as appeals court overturns dismissal of 2020 lawsuit
Fierce Pharma
Tue, 02/20/24 - 05:52 pm
Genzyme
Sanofi
Fabry disease
legal
Fabrazyme
Sanofi shares positive results from trial of frexalimab for MS
Clinical Trials Arena
Fri, 02/16/24 - 11:43 am
Sanofi
clinical trials
MS
multiple sclerosis
frexalimab
Denali-Sanofi's ALS drug fails to meet mid-stage trial goal
Reuters
Fri, 02/16/24 - 11:36 am
Denali Therapeutics
Sanofi
ALS
clinical trials
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
BioSpace
Sun, 02/11/24 - 03:50 pm
earnings
COVID-19
GLP-1 agonist
JNJ
Bristol Myers Squibb
Pfizer
AstraZeneca
Sanofi
Eli Lilly
Novo Nordisk
Could Dupixent find a new life targeting ‘memory’ B cells to treat allergies?
Fierce Biotech
Fri, 02/9/24 - 11:20 am
allergies
Dupixent
Sanofi
Sanofi and Medidata expand eCOA partnership to enhance trial efficiency
Clinical Trials Arena
Thu, 02/8/24 - 10:02 pm
Sanofi
vaccines
Medidata
clinical trials
eCOA
[podcast]Sanofi’s AI-assisted pipeline strategy, unpacked by R&D lead
Medical Marketing and Media
Thu, 02/8/24 - 11:15 am
Sanofi
R&D
artificial intelligence
Sanofi guarantees employees one year of salary and support after cancer diagnosis
Fierce Pharma
Tue, 02/6/24 - 09:38 am
Sanofi
cancer
employees
employee benefits
Sanofi, Takeda announce CFO changes as part of earnings releases
Medical Marketing and Media
Fri, 02/2/24 - 11:48 am
Sanofi
Takeda
CFOs
earnings
Sanofi expects RSV antibody to breach blockbuster status in 2024, even as supply hitch drags on
Fierce Pharma
Thu, 02/1/24 - 11:33 am
Sanofi
RSV
AstraZeneca
Beyfortus
Sanofi Q4 earnings hit by weak dollar, generic competition
Reuters
Thu, 02/1/24 - 11:25 am
Sanofi
earnings
Dupixent
Aubagio
Sanofi pays Synthekine $40M to join preclinical push against vexing inflammatory target
Fierce Biotech
Mon, 01/29/24 - 11:07 am
Sanofi
Synthekine
cytokines
inflammatory diseases
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »